Literature DB >> 29470238

CORR Insights®: Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.

Odion Binitie1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29470238      PMCID： PMC6259785          DOI： 10.1007/s11999.0000000000000203

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  7 in total

1.  CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.

Authors:  Philippe A Cassier; Antoine Italiano; Carlos A Gomez-Roca; Christophe Le Tourneau; Maud Toulmonde; Michael A Cannarile; Carola Ries; Anne Brillouet; Claudia Müller; Anna-Maria Jegg; Ann-Marie Bröske; Markus Dembowski; Katharine Bray-French; Christine Freilinger; Georgina Meneses-Lorente; Monika Baehner; Ross Harding; Jayantha Ratnayake; Keelara Abiraj; Nathalie Gass; Karen Noh; Randolph D Christen; Lidia Ukarma; Emmanuelle Bompas; Jean-Pierre Delord; Jean-Yves Blay; Dominik Rüttinger
Journal:  Lancet Oncol       Date:  2015-07-12       Impact factor: 41.316

Review 2.  Giant cell tumor of tendon sheath: largest single series in children.

Authors:  Purushottam A Gholve; Harish S Hosalkar; Portia A Kreiger; John P Dormans
Journal:  J Pediatr Orthop       Date:  2007 Jan-Feb       Impact factor: 2.324

3.  Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.

Authors:  Monique J L Mastboom; Floortje G M Verspoor; Daniël Uittenbogaard; Gerard R Schaap; Paul C Jutte; H W Bart Schreuder; Michiel A J van de Sande
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

4.  Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors.

Authors:  Emanuela Palmerini; Eric L Staals; Robert G Maki; Stefano Pengo; Angela Cioffi; Marco Gambarotti; Piero Picci; Primo Andrea Daolio; Antonina Parafioriti; Carol Morris; Cristina R Antonescu; Alessandro Gronchi; Paolo Giovanni Casali; Davide M Donati; Stefano Ferrari; Silvia Stacchiotti
Journal:  Eur J Cancer       Date:  2014-11-24       Impact factor: 9.162

5.  Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.

Authors:  William D Tap; Zev A Wainberg; Stephen P Anthony; Prabha N Ibrahim; Chao Zhang; John H Healey; Bartosz Chmielowski; Arthur P Staddon; Allen Lee Cohn; Geoffrey I Shapiro; Vicki L Keedy; Arun S Singh; Igor Puzanov; Eunice L Kwak; Andrew J Wagner; Daniel D Von Hoff; Glen J Weiss; Ramesh K Ramanathan; Jiazhong Zhang; Gaston Habets; Ying Zhang; Elizabeth A Burton; Gary Visor; Laura Sanftner; Paul Severson; Hoa Nguyen; Marie J Kim; Adhirai Marimuthu; Garson Tsang; Rafe Shellooe; Carolyn Gee; Brian L West; Peter Hirth; Keith Nolop; Matt van de Rijn; Henry H Hsu; Charles Peterfy; Paul S Lin; Sandra Tong-Starksen; Gideon Bollag
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

Review 6.  Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis.

Authors:  Mehdi Brahmi; Armelle Vinceneux; Philippe A Cassier
Journal:  Curr Treat Options Oncol       Date:  2016-02

7.  Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.

Authors:  Heather L Gelhorn; Sandra Tong; Kelly McQuarrie; Christina Vernon; Jennifer Hanlon; Grant Maclaine; William Lenderking; Xin Ye; Rebecca M Speck; Richard D Lackman; Susan V Bukata; John H Healey; Vicki L Keedy; Stephen P Anthony; Andrew J Wagner; Daniel D Von Hoff; Arun S Singh; Carlos R Becerra; Henry H Hsu; Paul S Lin; William D Tap
Journal:  Clin Ther       Date:  2016-04-01       Impact factor: 3.393
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.